| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PALISADE BIO, INC. | Director | Common Stock, par value $0.01 | 12,862 | $5,609 | $0.4361 | 08 Feb 2024 | Direct |
| PALISADE BIO, INC. | Director | Restricted Stock Units | 0 | $0 | $0.4361 | 08 Feb 2024 | Direct |
| IDERA PHARMACEUTICALS, INC. | Director | Stock Option (Right to Buy) | 26,000 | 23 Jun 2022 | Direct | ||
| PALISADE BIO, INC. | Director | Common Stock Options | 6,880 | 08 Feb 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PALI | PALISADE BIO, INC. | 08 Feb 2024 | 8 | $0 | 4 | Director | 13 Feb 2024, 15:08 |
| PALI | PALISADE BIO, INC. | 21 Nov 2023 | 2 | $0 | 4 | Director | 24 Nov 2023, 16:00 |
| PALI | PALISADE BIO, INC. | 11 Jun 2023 | 2 | $0 | 4 | Director | 13 Jun 2023, 18:44 |
| /report/000141588922006939-csimma-cristina-2022-06-23 | IDERA PHARMACEUTICALS, INC. | 23 Jun 2022 | 1 | $0 | 4 | Director | 27 Jun 2022, 16:30 |
| PALI | PALISADE BIO, INC. | 18 Nov 2021 | 1 | $0 | 4 | Director | 10 Feb 2022, 17:07 |
| /report/000141588921002916-csimma-cristina-2021-06-08 | IDERA PHARMACEUTICALS, INC. | 08 Jun 2021 | 1 | $0 | 4 | Director | 10 Jun 2021, 17:05 |